12.2 C
New York
Monday, June 5, 2023

The Street Is Finally Waking Up To Organogenesis Holdings Inc. (NASDAQ: ORGO)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Organogenesis Holdings Inc. (ORGO) shows that investor sentiment remained same, with the stock’s consolidated last price remained same to $2.12. The Organogenesis Holdings Inc. has recorded 8,972 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of Directors.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

Organogenesis Holdings Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Drug Manufacturers – Specialty & Generic industry. At the end of the last regular session, the stock closed at $2.12 and fluctuated between $2.1300 as its day high and $2.0200 as its day low. The current market capitalization of Organogenesis Holdings Inc. is $270.19M. A total of 0.89 million shares were traded on the day, compared to an average of 1.28M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, ORGO has seen 12 BUY and 13 SELL insider trades, representing the acquisition of 2,530,051 and the disposition of 48,148 shares. Over the last 12 months, there were 38 BUYs and 37 SELLs from insiders. Insiders purchased 4,309,906 shares during that period but sold 1,528,148.

In the most recent transaction, ERANI ALBERT sold 25,000 shares of ORGO for 2.07 per share on Apr 12. After the transaction, the 10% Owner now owns 59,223,027 company shares. In a previous transaction on Apr 12, ERANI ALBERT sold 25,000 shares at 2.07 per share. ORGO shares that 10% Owner owns now total 59,223,027.

Among the insiders who bought shares, KATZ MICHAEL W acquired of 3,000 shares on Nov 21 at a per-share price of $2.56. This resulted in the 10% Owner holding 76,382 shares of ORGO after the transaction. In another insider transaction, KATZ MICHAEL W bought 3,000 shares at $2.57 per share on Nov 18. Company shares held by the 10% Owner now total 73,382.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for ORGO in the last 3 months, the mean price target is $11.00 with high estimates of $11.00 and low estimates of $11.00. In terms of 52-week highs and lows, ORGO has a high of $7.27 and a low of $1.79.

As of this writing, ORGO has an earnings estimate of -$0.02 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.02 per share and a lower estimate of -$0.02. The company reported an EPS of $0 in the last quarter, which was -100.00% lower than expectations of $0.06.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ORGO’s latest balance sheet shows that the firm has $113.93M in Cash & Short Term Investments as of fiscal 2021. There were $132.30M in debt and $82.00M in liabilities at the time. Its Book Value Per Share was $2.03, while its Total Shareholder’s Equity was $242.03M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ORGO is Buy with a score of 3.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles